# AlloSure Lung Assessment and Metagenomics Outcomes Study

> **NCT05050955** · — · ACTIVE_NOT_RECRUITING · sponsor: **CareDx** · enrollment: 550 (actual)

## Conditions studied

- Lung Transplant Infection
- Lung Transplant; Complications
- Lung Transplant Failure and Rejection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05050955
- **Lead sponsor:** CareDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-29
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05050955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05050955, "AlloSure Lung Assessment and Metagenomics Outcomes Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05050955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*